NKTR Latest Quarter’s Earnings
Announce Date8/13/2026
EPS Actual (USD)-1.23
Revenue Actual (USD)10.13M
Nektar Therapeutics Earnings Dates & Reports
This page offers detailed Nektar Therapeutics earnings data including the latest Nektar Therapeutics earnings report, the upcoming Nektar Therapeutics earnings date, historical data and Nektar Therapeutics earnings call news.
NKTR Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
NKTR FY2025 Earnings
EPS (YoY)-9.73-12.09%
Revenue (YoY)55.23M-43.89%
Nektar Therapeutics (NKTR) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/13/2026 | 06/2026 | -1.23/-1.98 | 10.13M/10.42M | 38.08% | -2.82% |
| 5/7/2026 | 03/2026 | -1.82/-1.59 | 10.86M/10.64M | -13.83% | 2.11% |
| 3/12/2026 | 12/2025 | -1.77/-2.47 | 21.81M/10.40M | 28.29% | 109.61% |
| 11/6/2025 | 09/2025 | -1.87/-2.68 | 11.79M/10.05M | 30.16% | 17.33% |
| 8/7/2025 | 06/2025 | -2.95/-3.04 | 11.18M/10.85M | 2.72% | 3.01% |
| 5/8/2025 | 03/2025 | -3.62/-2.46 | 10.46M/15.36M | -46.83% | -31.89% |
| 3/12/2025 | 12/2024 | 0.52/-2.52 | 29.18M/29.86M | 120.57% | -2.29% |
| 11/7/2024 | 09/2024 | -2.66/-3.16 | 24.12M/18.28M | 16.01% | 31.96% |
Nektar Therapeutics Latest Earnings Call Transcripts
Nektar Therapeutics (NKTR) Q2 2026 Earnings Call: REZPEG Phase III Advances
Nektar Therapeutics Q2 2026 earnings call: $1.02 billion in cash, raised year-end cash guidance, and new timelines for REZPEG Phase III programs.